Valuation (10%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -17.75 | N/A |
PEG Ratio (TTM) | -0.24 | N/A |
P/S Ratio (TTM) | N/A | N/A |
P/B Ratio (TTM) | 1.16 | N/A |
P/FCF Ratio (TTM) | -35.55 | N/A |
Price to 5YR AVG Earnings Ratio | N/A | N/A |
Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -5.22% | N/A |
ROE (TTM) | -6.76% | N/A |
Net Profit Margin (TTM) | N/A | N/A |
ROIC 5YR AVG | N/A | N/A |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -19,358.36% | -308.77% | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -34,059.78% | -380.43% | N/A |
Cash Flow | N/A | -267.65% | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.76 | N/A |
Quick Ratio (TTM) | 1.76 | N/A |
D/E Ratio (TTM) | N/A | N/A |
Interest Coverage (TTM) | -1,312.77 | N/A |
Piotroski F-Score | 3 | N/A |
Altman Z-Score | 4.24 | N/A |
LTL to 5YR AVG FCF | N/A | N/A |
Shares Outstanding Growth 5YR AVG | N/A | N/A |